NIH's Dr. Dieffenbach Shares Perspectives From First Day of AIDS 2016
July 18, 2016
The 21st International AIDS Conference (AIDS 2016) opened in Durban, South Africa today. As we've done from other scientific conferences, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases (NIAID), to get some highlights from the day. We did our first-ever Facebook Live interview with him as the conference's first day drew to an end.
Dr. Dieffenbach reflected on how much has changed since the conference was last held in Durban 16 years ago. He also reviewed some highlights of advances in the response to HIV among women that were presented today at the conference, including NIH-supported research into a drug-infused vaginal ring to reduce the risk of HIV infection among women and progress in reducing mother-to-child transmission of HIV.
In case you missed it, you can view the recorded version of his Facebook Live conversation with his colleague Anne Rancourt below or on the AIDS.gov Facebook page.
This article was provided by HIV.gov. It is a part of the publication The 21st International AIDS Conference (AIDS 2016).
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.